These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12383477)

  • 21. Urinary profiling investigation of metabolites with cis-diol structure from cancer patients based on UPLC-MS and HPLC-MS as well as multivariate statistical analysis.
    Zhao X; Wang W; Wang J; Yang J; Xu G
    J Sep Sci; 2006 Nov; 29(16):2444-51. PubMed ID: 17154124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancer.
    Bullinger D; Fröhlich H; Klaus F; Neubauer H; Frickenschmidt A; Henneges C; Zell A; Laufer S; Gleiter CH; Liebich H; Kammerer B
    Anal Chim Acta; 2008 Jun; 618(1):29-34. PubMed ID: 18501242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of capillary electrophoresis in clinical chemistry: the clinical value of urinary modified nucleosides.
    Liebich HM; Lehmann R; Xu G; Wahl HG; Häring HU
    J Chromatogr B Biomed Sci Appl; 2000 Aug; 745(1):189-96. PubMed ID: 10997714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modified nucleosides in body fluids of tumor-bearing patients.
    Salvatore F; Colonna A; Costanzo F; Russo T; Esposito F; Cimino F
    Recent Results Cancer Res; 1983; 84():360-77. PubMed ID: 6844698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of urinary nucleosides as biological marker in cancer patients analyzed by micellar electrokinetic capillary chromatography.
    Zheng YF; Xu GW; Liu DY; Xiong JH; Zhang PD; Zhang C; Yang Q; Lv S
    Electrophoresis; 2002 Dec; 23(24):4104-9. PubMed ID: 12481266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection and characterization of modified nucleosides in serum and urine of uremic patients using capillary liquid chromatography-frit-fast atom bombardment mass spectrometry.
    Takeda N; Yoshizumi H; Niwa T
    J Chromatogr B Biomed Sci Appl; 2000 Sep; 746(1):51-62. PubMed ID: 11048740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulated plasma and urinary levels of nucleosides as biological markers in the diagnosis of primary gallbladder cancer.
    Jiao X; Mo Y; Wu Y; He J; Zhang P; Hu R; Luo C; Du J; Fu J; Shi J; Zhou L; Li D
    J Sep Sci; 2014 Nov; 37(21):3033-44. PubMed ID: 25137411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of modified nucleosides in the urine of patients with malignant cancer by liquid chromatography/electrospray ionization mass spectrometry.
    Li HY; Wang SM; Liu HM; Li J; Han D; Bu SS; Zhang MZ
    Rapid Commun Mass Spectrom; 2008 Oct; 22(20):3161-71. PubMed ID: 18798199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary modified nucleosides as novel biomarkers for diagnosis and prognostic monitoring of urothelial bladder cancer.
    Zhang YR; Shi L; Wu H; Tang DD; Wang SM; Liu HM; Zhang LR; Song DK
    Tumori; 2014; 100(6):660-6. PubMed ID: 25688500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromatographic, capillary electrophoretic and matrix-assisted laser desorption ionization time-of-flight mass spectrometry analysis of urinary modified nucleosides as tumor markers.
    Liebich HM; Müller-Hagedorn S; Klaus F; Meziane K; Kim KR; Frickenschmidt A; Kammerer B
    J Chromatogr A; 2005 Apr; 1071(1-2):271-5. PubMed ID: 15865203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of RP-HPLC columns used for determination of nucleoside metabolic patterns in urine of cancer patients.
    Waszczuk-Jankowska M; Markuszewski MJ; Markuszewski M; Kaliszan R
    Bioanalysis; 2012 Jun; 4(10):1185-94. PubMed ID: 22651562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The state-of-the-art determination of urinary nucleosides using chromatographic techniques "hyphenated" with advanced bioinformatic methods.
    Struck W; Waszczuk-Jankowska M; Kaliszan R; Markuszewski MJ
    Anal Bioanal Chem; 2011 Oct; 401(7):2039-50. PubMed ID: 21359827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Significance of urinary nucleosides in diagnosis of gastric carcinoma].
    Chen YJ; Zheng YF; Wang NF; Lu S; Pang T; Yang Q; Xu GW
    Ai Zheng; 2003 May; 22(5):537-40. PubMed ID: 12753721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rapid and sensitive method for quantitation of nucleosides in human urine using liquid chromatography/mass spectrometry with direct urine injection.
    Lee SH; Jung BH; Kim SY; Chung BC
    Rapid Commun Mass Spectrom; 2004; 18(9):973-7. PubMed ID: 15116424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis, identification and determination of urinary modified nucleosides of cancer and AIDS patients.
    Nakano K; Yasaka T; Nakao T; Schram KH; Hammargren WM
    Nucleic Acids Symp Ser; 1990; (22):31-2. PubMed ID: 2101906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of urinary nucleosides. V. Identification of urinary pyrimidine nucleosides by liquid chromatography/electrospray mass spectrometry.
    Bond A; Dudley E; Lemière F; Tuytten R; El-Sharkawi S; Brenton AG; Esmans EL; Newton RP
    Rapid Commun Mass Spectrom; 2006; 20(2):137-50. PubMed ID: 16331740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-dependence of urinary normal and modified nucleosides in childhood as determined by reversed-phase high-performance liquid chromatography.
    Liebich HM; Müller-Hagedorn S; Bacher M; Scheel-Walter HG; Lu X; Frickenschmidt A; Kammerer B; Kim KR; Gérard H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(2):275-83. PubMed ID: 15639449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted serum metabolite profiling of nucleosides in esophageal adenocarcinoma.
    Djukovic D; Baniasadi HR; Kc R; Hammoud Z; Raftery D
    Rapid Commun Mass Spectrom; 2010 Oct; 24(20):3057-62. PubMed ID: 20872639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A noninvasive cancer detection strategy based on gold nanoparticle surface-enhanced raman spectroscopy of urinary modified nucleosides isolated by affinity chromatography.
    Feng S; Zheng Z; Xu Y; Lin J; Chen G; Weng C; Lin D; Qiu S; Cheng M; Huang Z; Wang L; Chen R; Xie S; Zeng H
    Biosens Bioelectron; 2017 May; 91():616-622. PubMed ID: 28103517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using UHPLC Q-Trap/MS as a complementary technique to in-depth mine UPLC Q-TOF/MS data for identifying modified nucleosides in urine.
    Lu Z; Wang Q; Wang M; Fu S; Zhang Q; Zhang Z; Zhao H; Liu Y; Huang Z; Xie Z; Yu H; Gao X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Apr; 1051():108-117. PubMed ID: 28340480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.